ProPhase Labs, Inc. Earnings Per Share, Basic and Diluted
ProPhase Labs, Inc. (PRPH) reported Earnings Per Share, Basic and Diluted of -$0.26 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-12
- ProPhase Labs, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.26.
- ProPhase Labs, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.04, a 100.00% decline year-over-year.
- ProPhase Labs, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.07.
- ProPhase Labs, Inc. earnings per share, basic and diluted for the quarter ending 2019-09-30 was $11565000.00, a 0.21% increase year-over-year.
- ProPhase Labs, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.27.
- ProPhase Labs, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.15.
- ProPhase Labs, Inc. earnings per share, basic and diluted for fiscal 2016 was -$0.17.
- ProPhase Labs, Inc. earnings per share, basic and diluted for fiscal 2015 was -$0.22.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-09-30 | -$0.26 10-Q · filed 2021-11-12 | -$0.29 10-Q · filed 2021-11-12 | |||
| 2020-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2022-03-31 | ||||
| 2020-09-30 | -$0.04 10-Q · filed 2021-11-12 | -$0.10 10-Q · filed 2021-11-12 | |||
| 2020-03-31 | -$0.07 10-Q · filed 2020-05-12 | ||||
| 2019-12-31 | -$0.27 10-K · filed 2020-03-26 | ||||
| 2019-09-30 | $11565000.00 10-Q · filed 2019-11-12 | $11561000.00 10-Q · filed 2019-11-12 | |||
| 2019-03-31 | -$0.09 10-Q · filed 2020-05-12 | ||||
| 2018-12-31 | -$0.15 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $11541000.00 10-Q · filed 2019-11-12 | $11344000.00 10-Q · filed 2019-11-12 | |||
| 2016-12-31 | -$0.17 10-K · filed 2017-02-24 | ||||
| 2016-06-30 | -$0.06 10-Q · filed 2016-08-11 | -$0.14 10-Q · filed 2016-08-11 | |||
| 2016-03-31 | -$0.08 10-Q · filed 2016-05-13 | ||||
| 2015-12-31 | -$0.07 10-K · filed 2016-03-29 | -$0.22 10-K · filed 2017-02-24 | |||
| 2015-09-30 | $0.04 10-K · filed 2016-03-29 | ||||
| 2015-06-30 | -$0.10 10-Q · filed 2016-08-11 | -$0.18 10-Q · filed 2016-08-11 | |||
| 2015-03-31 | -$0.09 10-Q · filed 2016-05-13 | ||||
| 2014-12-31 | -$0.05 10-K · filed 2016-03-29 | -$0.47 10-K · filed 2017-02-24 | |||
| 2014-09-30 | -$0.18 10-K · filed 2016-03-29 | ||||
| 2014-06-30 | -$0.19 10-K · filed 2016-03-29 | -$235.92 derived: net income ÷ weighted average shares · filed 2015-08-12 | |||
| 2014-03-31 | -$0.05 10-K · filed 2016-03-29 | ||||
| 2013-06-30 | -$108.49 derived: net income ÷ weighted average shares · filed 2014-08-12 | -$90.45 derived: net income ÷ weighted average shares · filed 2014-08-12 | |||
| 2012-12-31 | $0.04 10-K · filed 2014-03-27 | -$0.07 10-K · filed 2013-03-28 | |||
| 2012-12-30 | $0.04 10-K · filed 2013-03-28 | ||||
| 2012-09-30 | $0.07 10-K · filed 2014-03-27 | -$0.10 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | -$0.13 10-K · filed 2014-03-27 | -$0.18 10-Q · filed 2012-08-13 | |||
| 2012-03-31 | -$0.05 10-K · filed 2014-03-27 | ||||
| 2011-12-31 | -$0.18 10-K · filed 2013-03-28 | ||||
| 2011-12-30 | -$0.12 10-K · filed 2013-03-28 | ||||
| 2011-09-30 | $0.07 10-K · filed 2013-03-28 | -$0.06 10-Q · filed 2012-11-14 | |||
| 2011-06-30 | -$0.07 10-K · filed 2013-03-28 | -$0.06 10-Q · filed 2011-08-12 | -$0.13 10-Q · filed 2012-08-13 | ||
| 2011-03-31 | -$0.07 10-K · filed 2013-03-28 | ||||
| 2010-12-31 | -$0.25 10-K · filed 2013-03-28 | ||||
| 2010-09-30 | $0.06 10-Q · filed 2011-11-14 | -$0.17 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | -$0.15 10-Q · filed 2011-08-12 | -$0.24 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | -$0.30 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |